1. Home
  2. AG vs BEAM Comparison

AG vs BEAM Comparison

Compare AG & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Majestic Silver Corp. (Canada)

AG

First Majestic Silver Corp. (Canada)

HOLD

Current Price

$19.56

Market Cap

8.5B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$24.73

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AG
BEAM
Founded
1979
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
2.6B
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
AG
BEAM
Price
$19.56
$24.73
Analyst Decision
Strong Buy
Buy
Analyst Count
3
12
Target Price
$21.92
$50.75
AVG Volume (30 Days)
7.8M
1.7M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
0.12%
N/A
EPS Growth
N/A
82.31
EPS
N/A
N/A
Revenue
N/A
$24,000.00
Revenue This Year
$24.41
N/A
Revenue Next Year
$10.68
$33.77
P/E Ratio
$143.01
N/A
Revenue Growth
N/A
33.33
52 Week Low
$10.19
$20.23
52 Week High
$32.00
$38.26

Technical Indicators

Market Signals
Indicator
AG
BEAM
Relative Strength Index (RSI) 49.65 40.17
Support Level $18.43 $21.63
Resistance Level $20.00 $28.87
Average True Range (ATR) 0.77 1.28
MACD -0.30 -0.39
Stochastic Oscillator 34.50 25.71

Price Performance

Historical Comparison
AG
BEAM

About AG First Majestic Silver Corp. (Canada)

First Majestic Silver Corp is in the business of production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. The company owns four producing mines in Mexico, consisting of the Santa Elena Silver/Gold Mine, the San Dimas Silver/Gold Mine, the Los Gatos Silver Mine, and the La Encantada Silver Mine. It also owns the Jerritt Canyon Gold Mine in Nevada, USA. Additionally, the firm holds interests in the San Martin Silver Mine and the Del Toro Silver Mine, and several exploration-stage projects. The majority of the company's revenues are from the sale of precious metals contained in dore and concentrate form. It generates maximum revenue from the sale of silver, followed by gold, zinc, copper, and other metals.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: